Publikationen von M. Uhr

Nothdurfter, C.; Tanasic, S.; Di Benedetto, B.; Uhr, M.; Kessler, J.; Wagner, E. M.; Gilling, K.; Parsons, C.; Rein, T.; Holsboer, F. et al.; Rupprecht, R.; Rammes, G.: Impact of lipid raft integrity on GABAA receptor function and its modulation by benzodiazepines. Pharmacopsychiatry 44 (6), S. 302 - 302 (2011)

Rosenhagen, M. C.; Uhr, M.: The Clinical Impact of ABCB1 Polymorphisms on the Treatment of Psychiatric Diseases. Current Pharmaceutical Design 17 (26), S. 2843 - 2851 (2011)

Szesny, N.; Brückl, T.; Pfister, H.; Hennings, J. M.; Klengel, T.; Menke, A.; Uhr, M.; Lucae, S.; Holsboer, F.; Ising, M. et al.; Zihl, J.: Effectiveness of a standardized cognitive training in depression and the interaction with HPA-axis regulation. Pharmacopsychiatry 44 (6), S. 308 - 308 (2011)

Erhardt, A.; Czibere, L.; Roeske, D.; Lucae, S.; Unschuld, P. G.; Ripke, S.; Specht, M.; Kohli, M. A.; Kloiber, S.; Ising, M. et al.; Heck, A.; Pfister, H.; Zimmermann, P.; Lieb, R.; Pütz, B.; Uhr, M.; Weber, P.; Deussing, J. M.; Gonik, M.; Bunck, M.; Kessler, M. S.; Frank, E.; Hohoff, C.; Domschke, K.; Krakowitzky, P.; Maier, W.; Bandelow, B.; Jacob, C.; Deckert, J.; Schreiber, S.; Strohmaier, J.; Nöthen, M.; Cichon, S.; Rietschel, M.; Bettecken, T.; Keck, M. E.; Landgraf, R.; Müller-Myhsok, B.; Holsboer, F.; Binder, E. B.: TMEM132D, a new candidate for anxiety phenotypes: evidence from human and mouse studies. Molecular Psychiatry 16 (6), S. 647 - 663 (2011)

Nischwitz, S.; Cepok, S.; Kroner, A.; Wolf, C.; Knop, M.; Müller-Sarnowski, F.; Pfister, H.; Rieckmann, P.; Hemmer, B.; Ising, M. et al.; Uhr, M.; Bettecken, T.; Holsboer, F.; Müller-Myhsok, B.; Weber, F.: More CLEC16A gene variants associated with multiple sclerosis. Acta Neurologica Scandinavica 123 (6), S. 400 - 406 (2011)

Hennings, J. M.; Kohli, M. A.; Czamara, D.; Heck, A.; Domschke, K.; Arolt, V.; Baune, B.; Horstmann, S.; Brueckl, T.; Klengel, T. et al.; Menke, A.; Müller-Myhsok, B.; Ising, M.; Uhr, M.; Holsboer, F.; Lucae, S.: BDNF and NTRK2 Polymorphisms and Antidepressant Treatment Response. Biological Psychiatry 69 (9 Suppl.1), S. 152 S - 152 S (2011)

Menke, A.; Klengel, T.; Eichelkraut, A.; Preis, L.; Rex-Haffner, M.; Uhr, M.; Holsboer, F.; Binder, E. B.: Glucocorticoid Induced FKBP5-gene Expression as a Biomarker for Depression? Biological Psychiatry 69 (9 Suppl.1), S. 153 S - 153 S (2011)

Sämann, P. G.; Kloiber, S.; Uhr, M.; Schumann-Späth, E.; Weber, F.: Nervous system affection in Evans' syndrome: case report and first description. Journal of Neurology 258 (Suppl. 1), S. 214 - 215 (2011)

Zimmermann, N.; Perisic, T.; Hafner, K.; Uhr, M.; Holsboer, F.; Zschocke, J.; Rein, T.: The epigenetic machinery of neural cells is modulated by psychoactive drugs. European Neuropsychopharmacology 21 (Suppl. 1), S. S21 - S22 (2011)

Eser, D.; Uhr, M.; Leicht, G.; Asmus, M.; Langer, A.; Schüle, C.; Baghai, T. C.; Mulert, C.; Rupprecht, R.: Glyoxalase-I mRNA expression and CCK-4 induced panic attacks. Journal of Psychiatric Research 45 (1), S. 60 - 63 (2011)

Kluge, M.; Schüssler, P.; Dresler, M.; Schmidt, D.; Yassouridis, A.; Uhr, M.; Steiger, A.: Effects of ghrelin on psychopathology, sleep and secretion of cortisol and growth hormone in patients with major depression. Journal of Psychiatric Research 45, S. 421 - 426 (2011)

Kohli, M. A.; Lucae, S.; Sämann, P. G.; Schmidt, M. V.; Demirkan, A.; Hek, K.; Roeske, D.; Alexander, M.; Salyakina, D.; Ripke, S. et al.; Hoehn, D.; Specht, M.; Menke, A.; Hennings, J.; Heck, A.; Ising, M.; Schreiber, S.; Czisch, M.; Müller, M. B.; Uhr, M.; Bettecken, T.; Becker, A.; Schramm, J.; Bradley, B.; Ressler, K. J.; Nöthen, M. M.; Cichon, S.; Hofmann, A.; Tiemeier, H.; van Duijn, C. M.; Holsboer, F.; Müller-Myhsok, B.; Binder, E. B.: The neuronal transporter gene SLC6A15 confers risk to major depression. Neuron 70, S. 252 - 265 (2011)

Paslakis, G.; Lecei, O.; Stalla, G. K.; Landgraf, R.; Uhr, M.; Hamann, B.; Luppa, P.; Gilles, M.; Heuser, I.; Deuschle, M.: The effect of treatment with ketoconazole on central CRH systems of depressed patients. Human Psychopharmacology-Clinical and Experimental 26 (1), S. 35 - 40 (2011)

Sarapas, C.; Cai, G. Q.; Bierer, L. M.; Golier, J. A.; Galea, S.; Ising, M.; Rein, T.; Schmeidler, J.; Müller-Myhsok, B.; Uhr, M. et al.; Holsboer, F.; Buxbaum, J. D.; Yehuda, R.: Genetic markers for PTSD risk and resilience among survivors of the World Trade Center attacks. Disease Markers 30 (2-3), S. 101 - 110 (2011)

Zimmermann, P.; Brückl, T.; Nocon, A.; Pfister, H.; Binder, E. B.; Uhr, M.; Lieb, R.; Moffitt, T. E.; Caspi, A.; Holsboer, F. et al.; Ising, M.: Interaction of FKBP5 gene variants and adverse life events in predicting depression onset: results from a 10-year prospective community study. American Journal of Psychiatry 168, S. 1107 - 1116 (2011)

Schmidt, M. V.; Trümbach, D.; Weber, P.; Wagner, K.; Scharf, S. H.; Liebl, C.; Datson, N.; Namendorf, C.; Gerlach, T.; Kühne, C. et al.; Uhr, M.; Deussing, J. M.; Wurst, W.; Binder, E. B.; Holsboer, F.; Müller, M. B.: Individual Stress Vulnerability Is Predicted by Short-Term Memory and AMPA Receptor Subunit Ratio in the Hippocampus. Journal of Neuroscience 30 (50), S. 16949 - 16958 (2010)

Heinzmann, J. M.; Thoeringer, C. K.; Knapman, A.; Palme, R.; Holsboer, F.; Uhr, M.; Landgraf, R.; Touma, C.: Intrahippocampal Corticosterone Response in Mice Selectively Bred for Extremes in Stress Reactivity: A Microdialysis Study. Journal of Neuroendocrinology 22 (11), S. 1187 - 1197 (2010)

Kirschbaum, K. M.; Uhr, M.; Holthoewer, D.; Namendorf, C.; Pietrzik, C.; Hiemke, C.; Schmitt, U.: Pharmacokinetics of acute and sub-chronic aripiprazole in P-glycoprotein deficient mice. Neuropharmacology 59 (6), S. 474 - 479 (2010)

Nischwitz, S.; Cepok, S.; Kroner, A.; Wolf, C.; Knop, M.; Müller-Sarnowski, F.; Pfister, H.; Roeske, D.; Rieckmann, P.; Hemmer, B. et al.; Ising, M.; Uhr, M.; Bettecken, T.; Holsboer, F.; Müller-Myhsok, B.; Weber, F.: Evidence for VAV2 and ZNF433 as susceptibility genes for multiple sclerosis. Journal of Neuroimmunology 227 (1-2), S. 162 - 166 (2010)

Kloiber, S.; Kohli, M. A.; Brueckl, T.; Ripke, S.; Ising, M.; Uhr, M.; Menke, A.; Unschuld, P. G.; Horstmann, S.; Salyakina, D. et al.; Müller-Myhsok, B.; Binder, E. B.; Holsboer, F.; Lucae, S.: Variations in tryptophan hydroxylase 2 linked to decreased serotonergic activity are associated with elevated risk for metabolic syndrome in depression. Molecular Psychiatry 15 (7), S. 736 - 747 (2010)